miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling-Reference-Cited by-同舟云学术

miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling

Published:2020-07-21 Issue:14 Volume:12 Page:14418-14433
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Wang Zhi-Chao¹,Li Yan²,Wang Ke-Liang¹,Wang Lu¹,You Bo-Sen¹,Zhao Dan-Feng¹,Liu Zhong-Qing¹,Fang Rui-Zhe¹,Wang Jia-Qi¹,Zhang Wei¹,Zhang Jin-Ming¹,Xu Wan-Hai¹

Affiliation:

1. Heilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China

2. Department of Anesthesia, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low temperature plasma suppresses proliferation, invasion, migration and survival of SK-BR-3 breast cancer cells;Molecular Biology Reports;2022-12-20

2. Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine;Human Cell;2022-09-02

3. Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics;Pharmacology & Therapeutics;2021-12

4. Retraction: miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling;Aging;2020-10-31